Jeffrey DiFrancesco

As Chief Product Officer, Mr. DiFrancesco overarching objective is to lead and facilitate the creation of products that deliver strategic and sustainable value across the entire product lifecycle — from customer discovery and user research to development and delivery. His professional conviction is “Closing the gap between vision and reality!”

With over thirty-five years of technology, healthcare, and life science experience, Mr. DiFrancesco is a specialist in companies with novel and market disruptive technologies. As an executive, he has planned and commercialized new businesses and product lines, and managed day-to-day profit-loss, operations and global strategic investments.  As a management consultant, he has advised many emerging and Fortune 500 organizations.

Mr. DiFrancesco currently is an adjunct Assistant Professor of Pharmaceutical Business, Philadelphia College of Pharmacy, University of the Sciences, where he teaches capital investment and finance management courses in its MBA program.  He also is active philanthropically, serving on several not-for-profit boards including, the Salvation Army (Board Officer, Executive Board, Task Force Chair), Girl Scouts Council of Eastern Pennsylvania (Property Committee), United Nations on Global Leadership and Capacity Development (OHRLLS) for Business Leading Global Change, Mayes College of Healthcare Business and Policy (Executive Board of Advisors), Boy Scouts of America (Executive Board) and National Adoption Center (Board Member).

He holds a Master of Science in Finance from Johns Hopkins University, a Master of Engineering in Engineering Science (Computer Design) from Penn State University, and a Bachelor of Science in Mathematics from Illinois Institute of Technology. He also has certificates in mergers and acquisitions from the Wharton School of the University of Pennsylvania, Level 1 Change Agent from Conner Partners, The Curriculum for Living from Landmark Education, and Black Belt Six Sigma from Goodwin College of Drexel University. He has published original research in journals, and chaired or spoken at over 32 industry conferences.